While these studies indicate that modulation of the KCa3.1 ion-channel could be of potential therapeutic benefit in asthma, the effect of KCa3.1 blockade on airway remodelling, inflammatory responses and functional airway responses in vivo is largely unknown. Here, KCNN4 is linked to asthma.